Intrinsic LifeSciences Awarded $4.45M SBIR Grant for Anemia Test Development | GenomeWeb

This article has been updated to correct the name of Intrinsic's CEO.

NEW YORK (GenomeWeb) – Intrinsic LifeSciences today said it has been awarded a $4.45 million Phase II Small Business Innovation Research grant to further develop its test for the differential diagnosis of a recently discovered genetically based form of anemia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.